Discover and read the best of Twitter Threads about #DAPACKD
Most recents (2)
Join here tomorrow for the launch of a new accredited tweetorial on the expanding role of #SGLT2i in CV disease! Earn 0.5 CE/CME credits: physicians, nurses, pharmacists! Expert faculty @mvaduganathan. #medtwitter @academiccme #diabetesmanagement @endocrinenetwrk
1) Welcome to a Tweetorial on #SGLT2i & CV health. “Flozinators of the world, unite!” Accredited for 0.50h by @academiccme: #physicians, #nurses, #pharmacists. I am @mvaduganathan . . . 
. . . and this educational activity, which is intended for healthcare providers, is supported by grants from Abbott, AstraZeneca, Bayer, Chiesi, and NovoNordisk.
💥DPA-CKD Trial results announced
⚡️Dapagliflozin lowered the risk of kidney failure and lowered mortality in both diabetic & non-diabetic patients
⚡️No episodes of hypoglycemia in non-diabetic patients
#ESCCongress #DAPACKD
⚡️Dapagliflozin lowered the risk of kidney failure and lowered mortality in both diabetic & non-diabetic patients
⚡️No episodes of hypoglycemia in non-diabetic patients
#ESCCongress #DAPACKD
Here is the full presentation (in short clips)
